As a result of that, both the American and the European association of the Study of the Liver (AASLD, EASL) suggest that in patients with AMA, gp-210 and/or anti-sp100 seropositivity, the diagnosis of PBC can be safely set with no liver biopsy (15, 16). The gene discussed is SP100; the disease is primary biliary cholangitis.